Finance

Lists
JHPCY:OTCMKTS
JIANGSU HENGRUI PHARMACEUTICALS ADR
$20.00
0.00%
(0.00) 1D
Aug 19, 9:30:02 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JHPCY...
Mkt. cap
338.36B
Avg. vol.
28.00
Volume
0.00
52-wk high
$20.00
52-wk low
$13.60
Shares outstanding
129.10M
No. of employees
21K
Mkt. cap
338.36B
Avg. vol.
28.00
Volume
0.00
52-wk high
$20.00
52-wk low
$13.60
Shares outstanding
129.10M
No. of employees
21K
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About JIANGSU HENGRUI PHARMACEUTICALS ADR
CEO-
Employees20.6K
FoundedApr 28, 1997
Headquarters-
SectorPharmaceutical industry
Websitehengrui.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.43B
8.44B
8.14B
7.32B
Cost of goods sold
1.07B
1.25B
1.09B
1.02B
Cost of revenue
1.07B
1.25B
1.09B
1.02B
Research and development expenses
1.72B
2.02B
1.65B
1.84B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.23B
3.01B
2.81B
2.78B
Operating expense
4.76B
5.35B
4.48B
4.61B
Total operating expenses
5.83B
6.60B
5.57B
5.63B
Operating income
1.60B
1.84B
2.57B
1.68B
Other non operating income
-154.21M
145.74M
-345.12M
243.91M
EBT including unusual items
1.36B
2.30B
2.56B
2.40B
EBT excluding unusual items
1.68B
1.91B
2.55B
1.60B
Income tax expense
55.51M
338.85M
275.87M
211.27M
Effective tax rate
4.08%
14.76%
10.79%
8.82%
Other operating expenses
-217.30M
326.84M
4.76M
-5.09M
Net income
1.30B
1.96B
2.28B
2.18B
Net profit margin
17.52%
23.22%
28.04%
29.84%
Earnings per share
0.20
-
-
-
Interest and investment income
242.14M
288.66M
322.96M
448.28K
Interest expense
-689.68K
-2.00M
-448.28K
-322.96M
Net interest expenses
241.45M
286.66M
322.52M
-322.52M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.78B
2.04B
2.77B
1.93B
Gain or loss from assets sale
2.31M
-4.05M
-
-40.62M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps